Overview
Frontotemporal Dementia Plasma
Frontotemporal Dementia Plasma is collected from IRB-consented donors diagnosed with clinically confirmed Frontotemporal Dementia. These plasma samples are ideal for detecting neurodegenerative biomarkers and inflammatory cytokines. Plasma samples support the development of early detection assays and provide insights into systemic biomarkers of frontotemporal dementia.
Product Features
- Cryopreserved, clinically verified frontotemporal dementia human plasma samples
- Cryopreserved to ensure stability and long-term storage
- Research Use Only (RUO)
Donor Metadata
- Clinically confirmed Frontotemporal Dementia diagnosis
- Donor demographics: age, sex assigned at birth, ethnicity
- Medical and treatment history available when applicable
Applications
- Detecting neurodegenerative biomarkers and inflammatory cytokines
- Biomarker discovery and validation
- Transcriptomic, proteomic, or functional studies
- Custom assay development and disease modeling
Compliance and Quality
- IRB-approved collection and electronic informed consent
- HIPAA-compliant donor data handling
Ordering and Customization
Frontotemporal Dementia Plasma is available in standard and custom volumes. Contact [email protected] for international requests or documentation needs.
Protocols and Documentation
Document Type | Technical Document |
---|---|
PDF > | Plasma Isolation |
Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.